Cargando…

Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging

BACKGROUND: The goal of this prospective study was to estimate the absorbed (radiation) doses to salivary glands in radioiodine therapy of thyroid cancer under chewing-gum stimulation using (124)I positron emission tomography (PET)/computed tomography (CT) imaging. METHODS: Duplex ultrasonography wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jentzen, Walter, Richter, Marion, Nagarajah, James, Poeppel, Thorsten Dirk, Brandau, Wolfgang, Dawes, Colin, Bockisch, Andreas, Binse, Ina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545453/
https://www.ncbi.nlm.nih.gov/pubmed/26501458
http://dx.doi.org/10.1186/s40658-014-0100-1
_version_ 1782386752247300096
author Jentzen, Walter
Richter, Marion
Nagarajah, James
Poeppel, Thorsten Dirk
Brandau, Wolfgang
Dawes, Colin
Bockisch, Andreas
Binse, Ina
author_facet Jentzen, Walter
Richter, Marion
Nagarajah, James
Poeppel, Thorsten Dirk
Brandau, Wolfgang
Dawes, Colin
Bockisch, Andreas
Binse, Ina
author_sort Jentzen, Walter
collection PubMed
description BACKGROUND: The goal of this prospective study was to estimate the absorbed (radiation) doses to salivary glands in radioiodine therapy of thyroid cancer under chewing-gum stimulation using (124)I positron emission tomography (PET)/computed tomography (CT) imaging. METHODS: Duplex ultrasonography was conducted in three test persons for visual comparison of the glandular blood flow with three different stimulation types (no stimulation, chewing tasteless gum base, sucking on lemon slices). Ten patients with newly diagnosed differentiated thyroid cancer received (124)I PET/CT dosimetry after thyroidectomy and prior to radioiodine therapy. Patients underwent a series of three (124)I PET/CT scans (4, 24, and ≥96 h after administration of 23 MBq (124)I). They were instructed to chew gum base (tasteless) approximately 20 min after ingesting the (124)I-containing capsule in the course of the first day. Absorbed doses per administered (131)I activity to the salivary glands were calculated and compared with the previously published results of the lemon-juice stimulation and non-stimulation groups. RESULTS: The sonograms in the three test persons showed that glandular blood perfusion by lemon-juice stimulation was clearly increased compared with non-stimulation or chewing of gum base. The sonogram comparison between the chewing-gum stimulation and non-stimulation demonstrated a minor increase of blood flow for the gum base-stimulated salivary glands. The mean ± standard deviation of the absorbed dose per activity under chewing-gum stimulation for the submandibular and parotid glands (within parentheses) was 0.22 ± 0.09 Gy/GBq (0.22 ± 0.08 Gy/GBq). Compared with the absorbed doses of the non-stimulation group, 0.24 ± 0.08 Gy/GBq (0.21 ± 0.05 Gy/GBq), those of the chewing-gum stimulation group showed no significant change (P > 0.60), but the absorbed doses of the lemon-juice stimulation group, 0.35 ± 0.14 Gy/GBq (0.33 ± 0.09 Gy/GBq), were significantly higher (P < 0.04) than those of the chewing-gum stimulation group. CONCLUSIONS: The results suggest that salivary flow induced by chewing gum base does not cause a significant reduction of the salivary gland absorbed dose compared with that in the non-stimulation group. The increased blood flow appears to be a decisive factor causing the increased (131)I absorbed doses in the lemon-juice stimulation group.
format Online
Article
Text
id pubmed-4545453
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-45454532015-08-26 Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging Jentzen, Walter Richter, Marion Nagarajah, James Poeppel, Thorsten Dirk Brandau, Wolfgang Dawes, Colin Bockisch, Andreas Binse, Ina EJNMMI Phys Original Research BACKGROUND: The goal of this prospective study was to estimate the absorbed (radiation) doses to salivary glands in radioiodine therapy of thyroid cancer under chewing-gum stimulation using (124)I positron emission tomography (PET)/computed tomography (CT) imaging. METHODS: Duplex ultrasonography was conducted in three test persons for visual comparison of the glandular blood flow with three different stimulation types (no stimulation, chewing tasteless gum base, sucking on lemon slices). Ten patients with newly diagnosed differentiated thyroid cancer received (124)I PET/CT dosimetry after thyroidectomy and prior to radioiodine therapy. Patients underwent a series of three (124)I PET/CT scans (4, 24, and ≥96 h after administration of 23 MBq (124)I). They were instructed to chew gum base (tasteless) approximately 20 min after ingesting the (124)I-containing capsule in the course of the first day. Absorbed doses per administered (131)I activity to the salivary glands were calculated and compared with the previously published results of the lemon-juice stimulation and non-stimulation groups. RESULTS: The sonograms in the three test persons showed that glandular blood perfusion by lemon-juice stimulation was clearly increased compared with non-stimulation or chewing of gum base. The sonogram comparison between the chewing-gum stimulation and non-stimulation demonstrated a minor increase of blood flow for the gum base-stimulated salivary glands. The mean ± standard deviation of the absorbed dose per activity under chewing-gum stimulation for the submandibular and parotid glands (within parentheses) was 0.22 ± 0.09 Gy/GBq (0.22 ± 0.08 Gy/GBq). Compared with the absorbed doses of the non-stimulation group, 0.24 ± 0.08 Gy/GBq (0.21 ± 0.05 Gy/GBq), those of the chewing-gum stimulation group showed no significant change (P > 0.60), but the absorbed doses of the lemon-juice stimulation group, 0.35 ± 0.14 Gy/GBq (0.33 ± 0.09 Gy/GBq), were significantly higher (P < 0.04) than those of the chewing-gum stimulation group. CONCLUSIONS: The results suggest that salivary flow induced by chewing gum base does not cause a significant reduction of the salivary gland absorbed dose compared with that in the non-stimulation group. The increased blood flow appears to be a decisive factor causing the increased (131)I absorbed doses in the lemon-juice stimulation group. Springer International Publishing 2014-12-06 /pmc/articles/PMC4545453/ /pubmed/26501458 http://dx.doi.org/10.1186/s40658-014-0100-1 Text en © Jentzen et al.; licensee Springer. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Original Research
Jentzen, Walter
Richter, Marion
Nagarajah, James
Poeppel, Thorsten Dirk
Brandau, Wolfgang
Dawes, Colin
Bockisch, Andreas
Binse, Ina
Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging
title Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging
title_full Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging
title_fullStr Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging
title_full_unstemmed Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging
title_short Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging
title_sort chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)i pet/ct imaging
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545453/
https://www.ncbi.nlm.nih.gov/pubmed/26501458
http://dx.doi.org/10.1186/s40658-014-0100-1
work_keys_str_mv AT jentzenwalter chewinggumstimulationdidnotreducetheabsorbeddosetosalivaryglandsduringradioiodinetreatmentofthyroidcancerasinferredfrompretherapy124ipetctimaging
AT richtermarion chewinggumstimulationdidnotreducetheabsorbeddosetosalivaryglandsduringradioiodinetreatmentofthyroidcancerasinferredfrompretherapy124ipetctimaging
AT nagarajahjames chewinggumstimulationdidnotreducetheabsorbeddosetosalivaryglandsduringradioiodinetreatmentofthyroidcancerasinferredfrompretherapy124ipetctimaging
AT poeppelthorstendirk chewinggumstimulationdidnotreducetheabsorbeddosetosalivaryglandsduringradioiodinetreatmentofthyroidcancerasinferredfrompretherapy124ipetctimaging
AT brandauwolfgang chewinggumstimulationdidnotreducetheabsorbeddosetosalivaryglandsduringradioiodinetreatmentofthyroidcancerasinferredfrompretherapy124ipetctimaging
AT dawescolin chewinggumstimulationdidnotreducetheabsorbeddosetosalivaryglandsduringradioiodinetreatmentofthyroidcancerasinferredfrompretherapy124ipetctimaging
AT bockischandreas chewinggumstimulationdidnotreducetheabsorbeddosetosalivaryglandsduringradioiodinetreatmentofthyroidcancerasinferredfrompretherapy124ipetctimaging
AT binseina chewinggumstimulationdidnotreducetheabsorbeddosetosalivaryglandsduringradioiodinetreatmentofthyroidcancerasinferredfrompretherapy124ipetctimaging